Floatz logo

Panitumumab-Irdye800

Pituitary Adenoma

Eben RosenthalEarly Phase 1
Rating in progress

Panitumumab-Irdye800 in Pituitary Adenoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active